ArticleAging2024

S100A9, as a potential predictor of prognosis and immunotherapy response for GBM, promotes the malignant progression of GBM cells and migration of M2 macrophages.

Qiankun Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.